15 completed, 1 unknown, 1 withdrawn. 17 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 17 | Completed 15, Unknown 1, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Microbial Collagenase: new trials by email Literature Review of Microbial Collagenase trials Research Report on Microbial Collagenase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA) Collagenase Clostridium Histolyticum (CCH), Placebo - Plantar Fasciitis | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 231 | 2024-01-03 | 2025-09-30 |
| CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques collagenase clostridium histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 35 | 2020-10-01 | 2022-09-28 |
| Clostridium Histolyticum Collagenase Injection for Urethral Disease Clostridium Histolyticum Collagenase, Saline - Urethral Stricture | Phase 2 | Completed | University of South Florida | 5 | 2020-05-22 | 2023-11-03 |
| Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) collagenase clostridium histolyticum (CCH) - Edematous Skin | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 64 | 2018-09-18 | 2023-09-07 |
| Safety and Effectiveness of EN3835 in the Treatment of EFP in Women Collagenase Clostridium Histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 158 | 2017-11-17 | 2020-12-29 |
| EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) Collagenase Clostridium Histolyticum - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 259 | 2016-10-05 | 2020-11-24 |
| EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, Placebo Comparator - Edematous Fibrosclerotic Panniculopathy, Cellulite | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 375 | 2016-02-01 | 2017-11-06 |
| Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma AA4500, placebo - Lipoma | Phase 2 | Completed | Gerut, Zachary, M.D. | 19 | 2014-08-01 | 2017-02-23 |
| Phase 2a Dose-Ranging Study to Evaluate Safety and Effectiveness of AA4500 in Treatment of Dupuytren's Disease Nodules Collagenase clostridium histolyticum, Placebo - Dupuytren's Disease | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 76 | 2014-07-01 | 2017-10-05 |
| Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder Collagenase Clostridium Histolyticum, Placebo - Adhesive Capsulitis, Frozen Shoulder | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 322 | 2013-11-01 | 2017-10-05 |
| A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy Collagenase Clostridium Histolyticum, Placebo - Edematous Fibrosclerotic Panniculopathy (EFP) | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 150 | 2013-10-01 | 2017-10-05 |
| A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma Collagenase Clostridium Histolyticum - Lipoma | Phase 2 | Completed | Zachary Gerut | 14 | 2012-05-01 | 2016-10-06 |
| AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder AA4500 0.29 mg/1 mL, AA4500 0.58 mg/2 mL, AA4500 0.58 mg/1 mL - Adhesive Capsulitis, Frozen Shoulder | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 50 | 2011-11-01 | 2017-10-05 |
| Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease AA4500 - Peyronie's Disease | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 20 | 2011-09-01 | 2017-10-05 |
| Injectable Collagenase For Burns' Associated Contracture Xiaflex (FDA approved collagenase) - Burn's Associated Contracture | Phase 2 | Unknown | Sheba Medical Center | 10 | 2011-03-01 | 2010-11-10 |
| Collagenase in the Treatment of Adhesive Capsulitis (Frozen Shoulder) Collagenase - Adhesive Capsulitis, Frozen Shoulder | Phase 2 | Withdrawn | Stony Brook University | 2006-01-01 | 2019-10-03 | |
| Collagenase in the Treatment of Zone II Flexor Tendon Adhesions in the Hand Collagenase, Collagenase injection - Adhesion of Flexor Tendon of Hand | Phase 1 / Phase 2 | Completed | Stony Brook University | 3 | 2005-01-01 | 2016-04-21 |
Cellulite (6) · Bursitis (3) · Lipoma (2) · Cutis Laxa (1) · Dupuytren Contracture (1) · Fasciitis, Plantar (1) · Penile Induration (1) · Shoulder Pain (1) · Urethral Stricture (1)
Endo USA Inc., a Keenova Therapeutics Company (11) · Stony Brook University (2) · Gerut, Zachary, M.D. (1) · Sheba Medical Center (1) · University of South Florida (1) · Zachary Gerut (1)
United States (16) · Australia (2) · Israel (1)
Marie A Badalamente, PhD (2) · Veronica Urdaneta, MD MPH (2) · David Hernandez (1) · Edward Wang, MD (1) · George Omburo (1) · Gregory J. Kaufman, MD (1) · Lucas R Wiegand, MD (1) · Mike McLane (1) · Mike McLane, PhD (1) · Neil H Schusterman, MD FACP (1) · Neil H Shusterman, MD FACP (1) · Zachary E Gerut, M.D. (1) · Zachary E Gerut, MD (1)
PMID 15541123, PMID 17437780, PMID 17617144, PMID 19726771, PMID 21315996, PMID 23376148, PMID 24745607, PMID 26126692, PMID 26491251, PMID 28854973, PMID 9679876